I copied/pasted the relevant information from the Retyne website.
” Graves’ eye disease, also known as Graves’ ophthalmopathy or thyroid eye disease (TED)”
see: https://retyne.com/graves-eye-disease/
It appears to address the “Symptoms” specifically inflammation
The Retyne Infrared Eye treatment mask offers a promising therapeutic option for individuals with Graves’ eye disease, providing targeted relief from inflammation and discomfort while promoting healing and improved eye function.
A General group is advised at Controller program 4:
Graves Eye Disease General Set use Program 4 or 0.06, 0.5, 0.87, 12.85, 27.5, 141, 301.23, 453.02, 783.4, 825.03
A specific group is advised for RDPV4. (Not available)
” Utilizing advanced hardware such as the RDPV4, a secondary set of specific frequencies for Graves Eye Disease (0.04, 1.52, 14.75, 71.87, 152.25, 142.5, 362.5, 402.5, 590, 822.53) is available. The RDPV4 offers an expanded range of frequencies, finely calibrated to provide even greater precision in addressing Graves Eye Disease.”
When using the Retyne Mask and controller for Thyroid Eye Disease: LOW intensity mode should be exclusively employed.
Rationale:
Extended therapy sessions at lower intensity demonstrated significantly superior long-term results compared to any treatments administered in HIGH mode. This conclusion is supported by observed clinical outcomes, reinforcing the preference for sustained, low-intensity application.
